• Je něco špatně v tomto záznamu ?

Donor and Recipient Matching in Facial Vascularized Composite Allotransplantation: A Closer Look at the Donor Pool

M. Kauke, V. Haug, D. Obed, Y. Diehm, B. Tchiloemba, AF. Safi, B. Pomahac

. 2021 ; 148 (1) : 194-202. [pub] 2021Jul01

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22000894

BACKGROUND: Identifying a donor for facial vascularized composite allotransplant recipients can be a lengthy, emotionally challenging process. Little is known about the relative distribution of key donor characteristics among potential donors. Data on actual wait times of patients are limited, making it difficult to estimate wait times for future recipients. METHODS: The authors retrospectively reviewed charts of nine facial vascularized composite allotransplant patients and provide data on transplant wait times and patient characteristics. In addition, they analyzed the United Network for Organ Sharing database of dead organ donors. After excluding donors with high-risk characteristics (e.g., active cancer or risk factors for blood-borne disease transmission), the authors calculated the distribution of relevant donor-recipient matching criteria (i.e., ethnicity, body mass index, age, ABO blood group, cytomegalovirus, Epstein-Barr virus, hepatitis C virus) among 65,201 potential donors. RESULTS: The median wait time for a transplant was 4 months (range, 1 day to 17 months). The large majority of United Network for Organ Sharing-recorded deaths from disease were white (63 percent) and male (58 percent). Female donors of black, Hispanic, or Asian descent are underrepresented, with 7, 5, and 1 percent of all recorded deaths from disease, respectively. Potential donors show cytomegalovirus and Epstein-Barr virus seropositivity of 65 and 95 percent, respectively. The number of annual hepatitis C-positive donors increased over time. CONCLUSIONS: Actual facial vascularized composite allotransplant wait times vary considerably. Although most patients experience acceptable wait times, some with underrepresented characteristics exceed acceptable levels. Cytomegalovirus-seropositive donors present a large portion of the donor pool, and exclusion for seronegative patients may increase wait time. Hepatitis C-seropositive donors may constitute a donor pool for underrepresented patient groups in the future.

000      
00000naa a2200000 a 4500
001      
bmc22000894
003      
CZ-PrNML
005      
20220106132548.0
007      
ta
008      
220106s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/PRS.0000000000008094 $2 doi
035    __
$a (PubMed)34181616
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kauke, Martin $u From the Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg
245    10
$a Donor and Recipient Matching in Facial Vascularized Composite Allotransplantation: A Closer Look at the Donor Pool / $c M. Kauke, V. Haug, D. Obed, Y. Diehm, B. Tchiloemba, AF. Safi, B. Pomahac
520    9_
$a BACKGROUND: Identifying a donor for facial vascularized composite allotransplant recipients can be a lengthy, emotionally challenging process. Little is known about the relative distribution of key donor characteristics among potential donors. Data on actual wait times of patients are limited, making it difficult to estimate wait times for future recipients. METHODS: The authors retrospectively reviewed charts of nine facial vascularized composite allotransplant patients and provide data on transplant wait times and patient characteristics. In addition, they analyzed the United Network for Organ Sharing database of dead organ donors. After excluding donors with high-risk characteristics (e.g., active cancer or risk factors for blood-borne disease transmission), the authors calculated the distribution of relevant donor-recipient matching criteria (i.e., ethnicity, body mass index, age, ABO blood group, cytomegalovirus, Epstein-Barr virus, hepatitis C virus) among 65,201 potential donors. RESULTS: The median wait time for a transplant was 4 months (range, 1 day to 17 months). The large majority of United Network for Organ Sharing-recorded deaths from disease were white (63 percent) and male (58 percent). Female donors of black, Hispanic, or Asian descent are underrepresented, with 7, 5, and 1 percent of all recorded deaths from disease, respectively. Potential donors show cytomegalovirus and Epstein-Barr virus seropositivity of 65 and 95 percent, respectively. The number of annual hepatitis C-positive donors increased over time. CONCLUSIONS: Actual facial vascularized composite allotransplant wait times vary considerably. Although most patients experience acceptable wait times, some with underrepresented characteristics exceed acceptable levels. Cytomegalovirus-seropositive donors present a large portion of the donor pool, and exclusion for seronegative patients may increase wait time. Hepatitis C-seropositive donors may constitute a donor pool for underrepresented patient groups in the future.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a Cytomegalovirus $x izolace a purifikace $7 D003587
650    _2
$a cytomegalovirové infekce $x krev $x diagnóza $x epidemiologie $x přenos $7 D003586
650    _2
$a výběr dárců $x normy $x statistika a číselné údaje $7 D046148
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a Hepacivirus $x izolace a purifikace $7 D016174
650    _2
$a hepatitida C $x krev $x diagnóza $x epidemiologie $7 D006526
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a časové faktory $7 D013997
650    _2
$a vaskularizovaná kompozitní alotransplantace $x normy $x statistika a číselné údaje $7 D063986
650    _2
$a seznamy čekatelů $7 D014850
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Haug, Valentin $u From the Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg
700    1_
$a Obed, Doha $u From the Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg
700    1_
$a Diehm, Yannick $u From the Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg
700    1_
$a Tchiloemba, Bianief $u From the Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg
700    1_
$a Safi, Ali-Farid $u From the Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg
700    1_
$a Pomahač, Bohdan $u From the Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School; and the Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg $d 1971- $7 xx0117402
773    0_
$w MED00010436 $t Plastic and reconstructive surgery $x 1529-4242 $g Roč. 148, č. 1 (2021), s. 194-202
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34181616 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220106 $b ABA008
991    __
$a 20220106132545 $b ABA008
999    __
$a ok $b bmc $g 1743229 $s 1152040
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 148 $c 1 $d 194-202 $e 2021Jul01 $i 1529-4242 $m Plastic and reconstructive surgery $n Plast Reconstr Surg $x MED00010436
LZP    __
$a Pubmed-20220106

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...